» Articles » PMID: 38830096

Epitranscriptomic Cytidine Methylation of the Hepatitis B Viral RNA is Essential for Viral Reverse Transcription and Particle Production

Overview
Specialty Science
Date 2024 Jun 3
PMID 38830096
Authors
Affiliations
Soon will be listed here.
Abstract

Epitranscriptomic RNA modifications have emerged as important regulators of the fate and function of viral RNAs. One prominent modification, the cytidine methylation 5-methylcytidine (mC), is found on the RNA of HIV-1, where mC enhances the translation of HIV-1 RNA. However, whether mC functionally enhances the RNA of other pathogenic viruses remains elusive. Here, we surveyed a panel of commonly found RNA modifications on the RNA of hepatitis B virus (HBV) and found that HBV RNA is enriched with mC as well as ten other modifications, at stoichiometries much higher than host messenger RNA (mRNA). Intriguingly, mC is mostly found on the epsilon hairpin, an RNA element required for viral RNA encapsidation and reverse transcription, with these mC mainly deposited by the cellular methyltransferase NSUN2. Loss of mC from HBV RNA due to NSUN2 depletion resulted in a partial decrease in viral core protein (HBc) production, accompanied by a near-complete loss of the reverse transcribed viral DNA. Similarly, mutations introduced to remove the methylated cytidines resulted in a loss of HBc production and reverse transcription. Furthermore, pharmacological disruption of mC deposition led to a significant decrease in HBV replication. Thus, our data indicate mC methylations as a critical mediator of the epsilon elements' function in HBV virion production and reverse transcription, suggesting the therapeutic potential of targeting the mC methyltransfer process on HBV epsilon as an antiviral strategy.

Citing Articles

RNA Modifications in Pathogenic Viruses: Existence, Mechanism, and Impacts.

Zou Y, Guo Z, Ge X, Qiu Y Microorganisms. 2024; 12(11).

PMID: 39597761 PMC: 11596894. DOI: 10.3390/microorganisms12112373.


Past, Present, and Future of RNA Modifications in Infectious Disease Research.

Pan X, Bruch A, Blango M ACS Infect Dis. 2024; 10(12):4017-4029.

PMID: 39569943 PMC: 11651297. DOI: 10.1021/acsinfecdis.4c00598.

References
1.
Squires J, Patel H, Nousch M, Sibbritt T, Humphreys D, Parker B . Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012; 40(11):5023-33. PMC: 3367185. DOI: 10.1093/nar/gks144. View

2.
Khoddami V, Cairns B . Identification of direct targets and modified bases of RNA cytosine methyltransferases. Nat Biotechnol. 2013; 31(5):458-64. PMC: 3791587. DOI: 10.1038/nbt.2566. View

3.
Burgess H, Depledge D, Thompson L, Srinivas K, Grande R, Vink E . Targeting the mA RNA modification pathway blocks SARS-CoV-2 and HCoV-OC43 replication. Genes Dev. 2021; 35(13-14):1005-1019. PMC: 8247602. DOI: 10.1101/gad.348320.121. View

4.
Feng J, Xu T, He M, Li J, Yao P, Ma C . NSUN2-mediated m5C modification of HBV RNA positively regulates HBV replication. PLoS Pathog. 2023; 19(12):e1011808. PMC: 10721180. DOI: 10.1371/journal.ppat.1011808. View

5.
Bohnsack K, Hobartner C, Bohnsack M . Eukaryotic 5-methylcytosine (m⁵C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease. Genes (Basel). 2019; 10(2). PMC: 6409601. DOI: 10.3390/genes10020102. View